Leyre Zubiri

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Leyre Zubiri

Sep 8, 2024, 16:13 | Insight

Tomas G. Neilan: Can large language models outperform ICD codes in detecting severe immune-related adverse events?

Tomas G. Neilan, Director of the Cardio-Oncology Program at Massachusetts General Hospital, shared on X:…

Sep 3, 2024, 16:29 | Insight

Jarushka Naidoo: Clinical + genetic factors associated with Type I diabetes from ICIs

Jarushka Naidoo shared a post on X: "Clinical + genetic factors associated with Type I diabetes…

Aug 5, 2024, 14:36 | Insight

5 papers about lung cancer suggested by Stephen Liu

Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…

Apr 14, 2024, 07:51 | Insight

New Paper Alert! Defining Dermatologic Immune-Related Adverse Events: A Consensus-Driven Approach

Defining Dermatologic Immune-Related Adverse Events: A Consensus-Driven Approach Published in Journal for ImmunoTherapy of Cancer,…

All: 4 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023